These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 2366822

  • 1. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ, Spaans F, De Baets MH.
    Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
    [Abstract] [Full Text] [Related]

  • 2. Repetitive nerve stimulation vs. twitch tension in rats with EAMG.
    Thompson PA, Barohn RA, Krolick KA.
    Muscle Nerve; 1992 Jan; 15(1):94-100. PubMed ID: 1732768
    [Abstract] [Full Text] [Related]

  • 3. [Clinical correlation of anti-receptor antibody titer, sensitivity to curare and electromyographic changes in experimental autoimmune myasthenia gravis].
    Chen SM.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):293-6, 320. PubMed ID: 2282884
    [Abstract] [Full Text] [Related]

  • 4. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes.
    Biesecker G, Koffler D.
    J Immunol; 1988 May 15; 140(10):3406-10. PubMed ID: 3258882
    [Abstract] [Full Text] [Related]

  • 5. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
    Losen M, Stassen MH, Martínez-Martínez P, Machiels BM, Duimel H, Frederik P, Veldman H, Wokke JH, Spaans F, Vincent A, De Baets MH.
    Brain; 2005 Oct 15; 128(Pt 10):2327-37. PubMed ID: 16150851
    [Abstract] [Full Text] [Related]

  • 6. Depletion of CD8+ T cells suppresses the development of experimental autoimmune myasthenia gravis in Lewis rats.
    Zhang GX, Ma CG, Xiao BG, Bakhiet M, Link H, Olsson T.
    Eur J Immunol; 1995 May 15; 25(5):1191-8. PubMed ID: 7774622
    [Abstract] [Full Text] [Related]

  • 7. [Acetylcholine receptor antibody titer, sensitivity to curare electromyogram and disease severity in myasthenia gravis].
    Chen SM.
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun 15; 24(3):169-73, 189. PubMed ID: 1889330
    [Abstract] [Full Text] [Related]

  • 8. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
    Fujii Y, Lindstrom J.
    J Immunol; 1988 Mar 15; 140(6):1830-7. PubMed ID: 2450133
    [Abstract] [Full Text] [Related]

  • 9. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
    Okumura S, McIntosh K, Drachman DB.
    Ann Neurol; 1994 Nov 15; 36(5):704-13. PubMed ID: 7979216
    [Abstract] [Full Text] [Related]

  • 10. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A, De Baets MH, Tzartos SJ, Lindstrom JM, Weigle WO, Theophilopoulos AN.
    Clin Exp Immunol; 1984 Jul 15; 57(1):41-50. PubMed ID: 6611231
    [Abstract] [Full Text] [Related]

  • 11. alpha-Bungarotoxin sensitization in experimental autoimmune myasthenia gravis.
    Kennel PF, Poindron P, Warter JM, Fonteneau P.
    Muscle Nerve; 1993 May 15; 16(5):461-5. PubMed ID: 8390605
    [Abstract] [Full Text] [Related]

  • 12. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I, Lovnićki TJ, Beara N, Taradi M.
    Lijec Vjesn; 1994 May 15; 116(5-6):158-61. PubMed ID: 7968205
    [Abstract] [Full Text] [Related]

  • 13. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL, Richman DP, Agius MA, Wollmann RL.
    J Immunol; 1987 May 15; 138(10):3269-75. PubMed ID: 3494763
    [Abstract] [Full Text] [Related]

  • 14. Stimulated-single fiber electromyography monitoring of anti-sense induced changes in experimental autoimmune myasthenia gravis.
    Boneva N, Hamra-Amitay Y, Wirguin I, Brenner T.
    Neurosci Res; 2006 May 15; 55(1):40-4. PubMed ID: 16504322
    [Abstract] [Full Text] [Related]

  • 15. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY, Qiao J, Melms A, Link H.
    Cell Immunol; 1993 Dec 15; 152(2):394-404. PubMed ID: 8258147
    [Abstract] [Full Text] [Related]

  • 16. The thymus in myasthenia gravis. Changes typical for the human disease are absent in experimental autoimmune myasthenia gravis of the Lewis rat.
    Meinl E, Klinkert WE, Wekerle H.
    Am J Pathol; 1991 Nov 15; 139(5):995-1008. PubMed ID: 1951638
    [Abstract] [Full Text] [Related]

  • 17. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM, Einarson BL, Lennon VA, Seybold ME.
    J Exp Med; 1976 Sep 01; 144(3):726-38. PubMed ID: 182896
    [Abstract] [Full Text] [Related]

  • 18. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis.
    Verschuuren JJ, Graus YM, Theunissen RO, Yamamoto T, Vincent A, van Breda Vriesman PJ, De Baets MH.
    J Neuroimmunol; 1992 Feb 01; 36(2-3):117-25. PubMed ID: 1732277
    [Abstract] [Full Text] [Related]

  • 19. Clonotypic analysis of anti-acetylcholine receptor antibodies from experimental autoimmune myasthenia gravis-sensitive Lewis rats and experimental autoimmune myasthenia gravis-resistant Wistar Furth rats.
    Zoda T, Yeh TM, Krolick KA.
    J Immunol; 1991 Jan 15; 146(2):663-70. PubMed ID: 1987281
    [Abstract] [Full Text] [Related]

  • 20. Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugates.
    Killen JA, Lindstrom JM.
    J Immunol; 1984 Nov 15; 133(5):2549-53. PubMed ID: 6332854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.